Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study With an Expansion Cohort of Duvelisib and Nivolumab in Mycosis Fungoides (MF) and Sézary Syndrome (SS)

NCT04652960 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT04652960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04652960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study With an Expansion Cohort of Duvelisib and Nivolumab in Mycosis Fungoides (MF) and Sézary Syndrome (SS)
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 21, 2021
Completion date
December 3, 2026
Enrollment
38 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

stage iib mycosis fungoides and sezary syndrome ajcc v8, stage iii mycosis fungoides and sezary syndrome ajcc v8, stage iv mycosis fungoides and sezary syndrome ajcc v8